Search Results

Business

IsoPlexis Reports Preliminary Full Year 2022 Revenue

IsoPlexis Corporation today announced its preliminary unaudited revenue for the full year ended December 31, 2022.

January 12, 2023

·

10 min read

Deals

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Berkeley Lights and IsoPlexis announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.

December 21, 2022

·

14 min read

Deals

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome.

March 21, 2023

·

6 min read

Pharm Country

IsoPlexis to Participate in Upcoming Investor Conferences - November 09, 2022

IsoPlexis Corporation, a company empowering labs to leverage the cells and proteome changing the course of human health, announced it will be participating in the following investor conferences.

November 9, 2022

·

1 min read

Business

IsoPlexis Reports Third Quarter 2022 Financial Results

IsoPlexis Corporation, a company empowering labs to leverage the cells and proteome changing the course of human health, reported financial results for the quarter ended September 30, 2022.

November 10, 2022

·

9 min read

Business

IsoPlexis Reports Second Quarter 2022 Financial Results

IsoPlexis Corporation today reported financial results for the quarter ended June 30, 2022.

August 10, 2022

·

9 min read

Business

IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

IsoPlexis Corporation today announced it will report financial results for the third quarter 2022 before market open on Thursday, November 10, 2022.

October 19, 2022

·

1 min read

Pharm Country

IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform

IsoPlexis Corporation announced the publication of initial data off its CodePlex platform in the journal Scientific Reports carried out by researchers at the Shanghai Institute of Hematology.

September 13, 2022

·

3 min read

Business

IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of Directors

IsoPlexis Corporation today announced the appointment of Nachum “Homi” Shamir to its Board of Directors as a Class II director.

August 23, 2022

·

6 min read

Pharm Country

IsoPlexis to Participate in Three Upcoming Investor Conferences

IsoPlexis Corporation, the Superhuman Cell Company, announced the company will be participating in the following investor conferences.

February 11, 2022

·

1 min read